RES 7011

Drug Profile

RES 7011

Alternative Names: KF 20704; RES-701-1

Latest Information Update: 13 Oct 2006

Price : $50

At a glance

  • Originator Kyowa Hakko
  • Class Antiasthmatics; Antihypertensives
  • Mechanism of Action Endothelin B receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Respiratory tract disorders

Most Recent Events

  • 13 Oct 2006 Discontinued - Preclinical for Respiratory tract disorders in Japan (unspecified route)
  • 12 Jun 2001 No-Development-Reported for Respiratory tract disorders in Japan (Unknown route)
  • 02 Sep 1996 Preclinical development for Respiratory tract disorders in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top